146 related articles for article (PubMed ID: 31176020)
1. Phosphodiesterase 3B (PDE3B) antagonizes the anti-angiogenic actions of PKA in human and murine endothelial cells.
MacKeil JL; Brzezinska P; Burke-Kleinman J; Theilmann AL; Nicol CJB; Ormiston ML; Maurice DH
Cell Signal; 2019 Oct; 62():109342. PubMed ID: 31176020
[TBL] [Abstract][Full Text] [Related]
2. Numerous distinct PKA-, or EPAC-based, signalling complexes allow selective phosphodiesterase 3 and phosphodiesterase 4 coordination of cell adhesion.
Raymond DR; Wilson LS; Carter RL; Maurice DH
Cell Signal; 2007 Dec; 19(12):2507-18. PubMed ID: 17884339
[TBL] [Abstract][Full Text] [Related]
3. Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice.
Sun B; Li H; Shakur Y; Hensley J; Hockman S; Kambayashi J; Manganiello VC; Liu Y
Cell Signal; 2007 Aug; 19(8):1765-71. PubMed ID: 17482796
[TBL] [Abstract][Full Text] [Related]
4. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
Murthy KS; Zhou H; Makhlouf GM
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C508-17. PubMed ID: 11832336
[TBL] [Abstract][Full Text] [Related]
5. Regulation of AMP-activated protein kinase by cAMP in adipocytes: roles for phosphodiesterases, protein kinase B, protein kinase A, Epac and lipolysis.
Omar B; Zmuda-Trzebiatowska E; Manganiello V; Göransson O; Degerman E
Cell Signal; 2009 May; 21(5):760-6. PubMed ID: 19167487
[TBL] [Abstract][Full Text] [Related]
6. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells.
Ahmad F; Cong LN; Stenson Holst L; Wang LM; Rahn Landstrom T; Pierce JH; Quon MJ; Degerman E; Manganiello VC
J Immunol; 2000 May; 164(9):4678-88. PubMed ID: 10779773
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Tilley DG; Maurice DH
Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
[TBL] [Abstract][Full Text] [Related]
9. A phosphodiesterase 3B-based signaling complex integrates exchange protein activated by cAMP 1 and phosphatidylinositol 3-kinase signals in human arterial endothelial cells.
Wilson LS; Baillie GS; Pritchard LM; Umana B; Terrin A; Zaccolo M; Houslay MD; Maurice DH
J Biol Chem; 2011 May; 286(18):16285-96. PubMed ID: 21393242
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor alpha and cAMP.
Rahn Landström T; Mei J; Karlsson M; Manganiello V; Degerman E
Biochem J; 2000 Mar; 346 Pt 2(Pt 2):337-43. PubMed ID: 10677351
[TBL] [Abstract][Full Text] [Related]
11. Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells.
Netherton SJ; Sutton JA; Wilson LS; Carter RL; Maurice DH
Circ Res; 2007 Oct; 101(8):768-76. PubMed ID: 17717302
[TBL] [Abstract][Full Text] [Related]
12. Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues.
Palmer D; Maurice DH
Mol Pharmacol; 2000 Aug; 58(2):247-52. PubMed ID: 10908291
[TBL] [Abstract][Full Text] [Related]
13. Altered phosphodiesterase 3-mediated cAMP hydrolysis contributes to a hypermotile phenotype in obese JCR:LA-cp rat aortic vascular smooth muscle cells: implications for diabetes-associated cardiovascular disease.
Netherton SJ; Jimmo SL; Palmer D; Tilley DG; Dunkerley HA; Raymond DR; Russell JC; Absher PM; Sage EH; Vernon RB; Maurice DH
Diabetes; 2002 Apr; 51(4):1194-200. PubMed ID: 11916944
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and activation of hormone-sensitive adipocyte phosphodiesterase type 3B.
Degerman E; Landström TR; Wijkander J; Holst LS; Ahmad F; Belfrage P; Manganiello V
Methods; 1998 Jan; 14(1):43-53. PubMed ID: 9500857
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP phosphodiesterases in human lymphocytes.
Sheth SB; Chaganti K; Bastepe M; Ajuria J; Brennan K; Biradavolu R; Colman RW
Br J Haematol; 1997 Dec; 99(4):784-9. PubMed ID: 9432022
[TBL] [Abstract][Full Text] [Related]
16. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
Rose RJ; Liu H; Palmer D; Maurice DH
Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
[TBL] [Abstract][Full Text] [Related]
17. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase Akt.
Kitamura T; Kitamura Y; Kuroda S; Hino Y; Ando M; Kotani K; Konishi H; Matsuzaki H; Kikkawa U; Ogawa W; Kasuga M
Mol Cell Biol; 1999 Sep; 19(9):6286-96. PubMed ID: 10454575
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanisms of the regulation of protein kinase B in adipocytes; implications for protein kinase A, Epac, phosphodiesterases 3 and 4.
Zmuda-Trzebiatowska E; Manganiello V; Degerman E
Cell Signal; 2007 Jan; 19(1):81-6. PubMed ID: 16839743
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis.
Osinski MT; Schrör K
Biochem Pharmacol; 2000 Aug; 60(3):381-7. PubMed ID: 10856433
[TBL] [Abstract][Full Text] [Related]
20. Regulation of sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) activity by phosphodiesterase 3A (PDE3A) in human myocardium: phosphorylation-dependent interaction of PDE3A1 with SERCA2.
Ahmad F; Shen W; Vandeput F; Szabo-Fresnais N; Krall J; Degerman E; Goetz F; Klussmann E; Movsesian M; Manganiello V
J Biol Chem; 2015 Mar; 290(11):6763-76. PubMed ID: 25593322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
